DMD and Duchenne muscular dystrophy: However, delivery of relatively high doses of unmodified Morpholinos into dystrophic muscle in animal models of DMD has induced expression of functional Dystrophin in skeletal muscle [9,10] and unmodified Morpholinos are currently in clinical trial for treatment of DMD (http://clinicaltrials.gov/ct2/show/NCT00844597).